Activation of NLRC4 and NLRP3 inflammasomes in microglia and astrocytes, as well as the upregulation of IRF3 and IRF7, contribute to the poor prognosis of glioma [79]. The gene discussed is NLRC4; the disease is central nervous system cancer.